Edited by:
Gabriele Picco, PhD, Translational Cancer Genomics Group, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom
Katia Grillone, PhD, Department of Experimental and Clinical Medicine, Oncology Laboratory, University Magna Graecia, Catanzaro, Italy
Sabrina Strano, PhD, SAFU Unit, Istituto di Ricovero e Cura a Carattere Scientifico, Regina Elena National Cancer Institute, Rome, Italy
Alice Castelli, PhD, Managing Editor Journal of Experimental & Clinical Cancer Research, Istituto di Ricovero e Cura a Carattere Scientifico, Regina Elena National Cancer Institute, Italy
Submission Status: Open | Submission Deadline: 30th June 2024
Journal of Experimental & Clinical Cancer Research is calling for submissions to our Collection on 'CRISPR-Cas9 system, the next generation in cancer therapy and target discovery.' This special issue aims to focus on recent and innovative applications of the CRISPR-Cas9 system in cancer research and therapy.